Home   Package List   Routine Alphabetical List   Global Alphabetical List   FileMan Files List   FileMan Sub-Files List   Package Component Lists   Package-Namespace Mapping  
Routine: IBDEI0PU

IBDEI0PU.m

Go to the documentation of this file.
  1. IBDEI0PU ; ; 01-FEB-2022
  1. ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
  1. Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
  1. Q Q
  1. ;;^UTILITY(U,$J,358.3,11616,1,4,0)
  1. ;;=4^I13.11
  1. ;;^UTILITY(U,$J,358.3,11616,2)
  1. ;;=^5007069
  1. ;;^UTILITY(U,$J,358.3,11617,0)
  1. ;;=I13.2^^46^563^7
  1. ;;^UTILITY(U,$J,358.3,11617,1,0)
  1. ;;=^358.31IA^4^2
  1. ;;^UTILITY(U,$J,358.3,11617,1,3,0)
  1. ;;=3^HTN Hrt & CKD w/ Hrt Failure w/ Stage 5 Chr Kidney/ESRD
  1. ;;^UTILITY(U,$J,358.3,11617,1,4,0)
  1. ;;=4^I13.2
  1. ;;^UTILITY(U,$J,358.3,11617,2)
  1. ;;=^5007070
  1. ;;^UTILITY(U,$J,358.3,11618,0)
  1. ;;=I70.1^^46^563^3
  1. ;;^UTILITY(U,$J,358.3,11618,1,0)
  1. ;;=^358.31IA^4^2
  1. ;;^UTILITY(U,$J,358.3,11618,1,3,0)
  1. ;;=3^Atherosclerosis of Renal Artery
  1. ;;^UTILITY(U,$J,358.3,11618,1,4,0)
  1. ;;=4^I70.1
  1. ;;^UTILITY(U,$J,358.3,11618,2)
  1. ;;=^269760
  1. ;;^UTILITY(U,$J,358.3,11619,0)
  1. ;;=I77.3^^46^563^2
  1. ;;^UTILITY(U,$J,358.3,11619,1,0)
  1. ;;=^358.31IA^4^2
  1. ;;^UTILITY(U,$J,358.3,11619,1,3,0)
  1. ;;=3^Arterial Fibromuscular Dysplasia
  1. ;;^UTILITY(U,$J,358.3,11619,1,4,0)
  1. ;;=4^I77.3
  1. ;;^UTILITY(U,$J,358.3,11619,2)
  1. ;;=^5007812
  1. ;;^UTILITY(U,$J,358.3,11620,0)
  1. ;;=E26.02^^46^563^5
  1. ;;^UTILITY(U,$J,358.3,11620,1,0)
  1. ;;=^358.31IA^4^2
  1. ;;^UTILITY(U,$J,358.3,11620,1,3,0)
  1. ;;=3^Glucocorticoid-Remediable Aldosteronism
  1. ;;^UTILITY(U,$J,358.3,11620,1,4,0)
  1. ;;=4^E26.02
  1. ;;^UTILITY(U,$J,358.3,11620,2)
  1. ;;=^329904
  1. ;;^UTILITY(U,$J,358.3,11621,0)
  1. ;;=I12.9^^46^563^14
  1. ;;^UTILITY(U,$J,358.3,11621,1,0)
  1. ;;=^358.31IA^4^2
  1. ;;^UTILITY(U,$J,358.3,11621,1,3,0)
  1. ;;=3^Hypertensive CKD Stage 1-4
  1. ;;^UTILITY(U,$J,358.3,11621,1,4,0)
  1. ;;=4^I12.9
  1. ;;^UTILITY(U,$J,358.3,11621,2)
  1. ;;=^5007066
  1. ;;^UTILITY(U,$J,358.3,11622,0)
  1. ;;=I12.0^^46^563^15
  1. ;;^UTILITY(U,$J,358.3,11622,1,0)
  1. ;;=^358.31IA^4^2
  1. ;;^UTILITY(U,$J,358.3,11622,1,3,0)
  1. ;;=3^Hypertensive CKD Stage 5 or ESRD
  1. ;;^UTILITY(U,$J,358.3,11622,1,4,0)
  1. ;;=4^I12.0
  1. ;;^UTILITY(U,$J,358.3,11622,2)
  1. ;;=^5007065
  1. ;;^UTILITY(U,$J,358.3,11623,0)
  1. ;;=I13.0^^46^563^6
  1. ;;^UTILITY(U,$J,358.3,11623,1,0)
  1. ;;=^358.31IA^4^2
  1. ;;^UTILITY(U,$J,358.3,11623,1,3,0)
  1. ;;=3^HTN Hrt & CKD w/ Hrt Failure w/ Stage 1-4 Chr Kidney
  1. ;;^UTILITY(U,$J,358.3,11623,1,4,0)
  1. ;;=4^I13.0
  1. ;;^UTILITY(U,$J,358.3,11623,2)
  1. ;;=^5007067
  1. ;;^UTILITY(U,$J,358.3,11624,0)
  1. ;;=I13.10^^46^563^9
  1. ;;^UTILITY(U,$J,358.3,11624,1,0)
  1. ;;=^358.31IA^4^2
  1. ;;^UTILITY(U,$J,358.3,11624,1,3,0)
  1. ;;=3^HTN Hrt & CKD w/o Hrt Failure w/ Stage 1-4 Chr Kidney
  1. ;;^UTILITY(U,$J,358.3,11624,1,4,0)
  1. ;;=4^I13.10
  1. ;;^UTILITY(U,$J,358.3,11624,2)
  1. ;;=^5007068
  1. ;;^UTILITY(U,$J,358.3,11625,0)
  1. ;;=I15.1^^46^563^11
  1. ;;^UTILITY(U,$J,358.3,11625,1,0)
  1. ;;=^358.31IA^4^2
  1. ;;^UTILITY(U,$J,358.3,11625,1,3,0)
  1. ;;=3^Hypertension Secondary to Oth Renal Disorders
  1. ;;^UTILITY(U,$J,358.3,11625,1,4,0)
  1. ;;=4^I15.1
  1. ;;^UTILITY(U,$J,358.3,11625,2)
  1. ;;=^5007072
  1. ;;^UTILITY(U,$J,358.3,11626,0)
  1. ;;=I15.2^^46^563^10
  1. ;;^UTILITY(U,$J,358.3,11626,1,0)
  1. ;;=^358.31IA^4^2
  1. ;;^UTILITY(U,$J,358.3,11626,1,3,0)
  1. ;;=3^Hypertension Secondary to Endocrine Disorders
  1. ;;^UTILITY(U,$J,358.3,11626,1,4,0)
  1. ;;=4^I15.2
  1. ;;^UTILITY(U,$J,358.3,11626,2)
  1. ;;=^5007073
  1. ;;^UTILITY(U,$J,358.3,11627,0)
  1. ;;=I50.1^^46^563^16
  1. ;;^UTILITY(U,$J,358.3,11627,1,0)
  1. ;;=^358.31IA^4^2
  1. ;;^UTILITY(U,$J,358.3,11627,1,3,0)
  1. ;;=3^Left Ventricular Failure
  1. ;;^UTILITY(U,$J,358.3,11627,1,4,0)
  1. ;;=4^I50.1
  1. ;;^UTILITY(U,$J,358.3,11627,2)
  1. ;;=^5007238
  1. ;;^UTILITY(U,$J,358.3,11628,0)
  1. ;;=E26.09^^46^563^17
  1. ;;^UTILITY(U,$J,358.3,11628,1,0)
  1. ;;=^358.31IA^4^2
  1. ;;^UTILITY(U,$J,358.3,11628,1,3,0)
  1. ;;=3^Primary Hyperaldosteronism,Other
  1. ;;^UTILITY(U,$J,358.3,11628,1,4,0)
  1. ;;=4^E26.09